Both pathways can counteract neuroendocrine overactivation and inhibit the release of renin and aldosterone, resulting in vasodilation, inhibition of cardiac hypertrophy, reduction of cardiac preload, and improvement of ventricular remodeling. Here, REN is linked to cardiac hypertrophy.